Association between lipoprotein(a) and coronary heart disease risk in type 2 diabetes mellitus and evaluation of statin treatment effects

Lipoprotein(a) is an independent risk factor for coronary heart disease in type 2 diabetes mellitus patients. Lipid-lowering therapy with statins alone cannot reduce lipoprotein(a) levels.

Authors

Institutions

Publication Details

Journal
Revista da Associação Médica Brasileira
Published
2025-01-01
DOI
https://doi.org/10.1590/1806-9282.20240870
Citations
3
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
6.02
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association between lipoprotein(a) and coronary heart disease risk in type 2 diabetes mellitus and evaluation of statin treatment effects

Liwu Xu, Li Li
3 citations
Revista da Associação Médica Brasileira
Lipoproteins and Cardiovascular Health
6.02
article

Association between lipoprotein(a) and coronary heart disease risk in type 2 diabetes mellitus and evaluation of statin treatment effects

Liwu Xu, Li Li
article en
3 citations

Abstract

Lipoprotein(a) is an independent risk factor for coronary heart disease in type 2 diabetes mellitus patients. Lipid-lowering therapy with statins alone cannot reduce lipoprotein(a) levels.

Revista da Associação Médica BrasileiraVol. 71(1)
Bengbu Medical College (CN), Anhui University of Science and Technology (CN)
Good health and well-being
Openalex Percentile: Top 5%
Lipoproteins and Cardiovascular Health
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.